Armored RNA technology as a clinical diagnostics tool for future pandemic preparedness

Area of Science:

• Biotechnology
• Molecular Biology
• Virology

Background:

• The COVID-19 pandemic exposed critical vulnerabilities in molecular diagnostic systems, particularly concerning delays and reagent instability.
• Existing diagnostic platforms often struggle with nuclease degradation and require stringent handling conditions.

Purpose of the Study:

• To highlight the advantages of Armored RNA technology as a robust solution for molecular diagnostics and its potential in future pandemic response.
• To explore recent advancements and future applications of Armored RNA in diagnostics, vaccines, and therapeutics.

Main Methods:

• Utilizing bacteriophage-derived capsids to encapsulate RNA, providing nuclease resistance and enhanced stability.
• Leveraging alternative expression systems (plant-based, cell-free) and optimized bacteriophage scaffolds (Qβ) for improved production.
• Implementing engineering innovations like capsid polymorphism and advanced purification techniques.

Main Results:

• Armored RNA serves as a reliable control for RT-qPCR and RT-LAMP, ensuring accurate detection of diverse viral pathogens.
• Advancements have significantly enhanced the yield, stability, and accessibility of Armored RNA.
• Engineering innovations have improved efficiency and expanded the application scope of the technology.

Conclusions:

• Armored RNA technology is a vital component for global health preparedness, strengthening diagnostic resilience against pandemics.
• Its potential extends beyond diagnostics to serving as a delivery vehicle for novel vaccines and targeted therapies, aligning with precision medicine.
• The adaptability and scalability of Armored RNA position it as a key technology for future biomedical countermeasures.